MedPage Today on MSN
Ultrasound treatment for prostate cancer has early advantage versus prostatectomy
Better continence, erectile function, but data on oncologic outcomes still 2 years away ...
Mammotome, a Danaher company, announces FDA Clearance of two innovations for MR-guided breast biopsy: the Mammotome Prima™ MR ...
The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy ...
The 2026 European Association of Urology (EAU) annual meeting featured a PARP inhibitors for prostate cancer session and a presentation by Dr. Martin Gleave discussing how to optimize tissue biopsy ...
Esaote presents its new and innovative technology dedicated to urology: the exclusive Prostate Attention Map (PAM), now ...
The Local Anesthetic Transperineal Prostate biopsy is associated with lower rates of infection and sepsis compared with the ...
The technology is available on the new MyLabE85 GTS Edition that will be showcased together with the brand new MyLabC30 GTS ...
Prof. Nicolas Barry-Delongchamps, Professor of Urology at Cochin Hospital and Principal Investigator of the VIOLETTE trial, will present the final results and one-year patients follow-up from the ...
BACKGROUND: Prostate biopsy is the recommended diagnostic test for prostate cancer in patients with abnormal findings on digital rectal examinations (DRE) or elevated PSA (prostate-specific antigen) ...
Olympus' Newest Needle for Endoscopic Ultrasound-Guided Biopsy is Designed to Offer Precision Sampling When Access Matters Most CENTER VALLEY, Pa., Jan. 28, 2026 /PRNewswire/ -- Olympus Corp. of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results